Hubert Walinski

Director/Board Member at CIPHER PHARMACEUTICALS INC.

Net worth: 26 218 $ as of 2026-09-29

Health Technology

Consumer Services

Finance

Profile

Dr. Hubert Walinski is an Independent Director at Cipher Pharmaceuticals, Inc., a Chief Scientific Officer at Portland Holdings, Inc. and a Chief Scientific Officer at Aic Global Holdings, Inc. He is on the Board of Directors at Cipher Pharmaceuticals, Inc. Dr. Walinski was previously employed as a Head-Medical Respiratory, Immunology & Vaccines by AstraZeneca Canada, Inc. He received his undergraduate degree from McMaster University and a doctorate degree from the University of British Columbia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CIPHER PHARMACEUTICALS INC. 0.01%	2026-06-23	2,689 ( 0.01% )	26 218 $	2026-09-29

Hubert Walinski active positions

Companies	Position	Start
CIPHER PHARMACEUTICALS INC.	Director/Board Member	2023-06-20
Aic Global Holdings, Inc. Aic Global Holdings, Inc. Aic Global Holdings, Inc. is a privately held investment company headquartered in Portland Holdings. Aic Global Holdings, Inc. owns a diverse portfolio of businesses in various sectors, including media, tourism, and financial services. The company's investment philosophy is focused on enabling Canadian technologies. The company has been involved in the construction of the world's first micro-modular reactor at the Canadian Nuclear Laboratories (CNL). Aic Global Holdings has also collaborated with MBM Holding on healthcare and clean energy sectors of national importance. The company has been appointed to the supervisory board of ITM Isotopen Technologien München AG, a pharmaceutical group of companies. The company is based in Burlington, Canada. The CEO of the company is Joseph Sferrazza.	Chief Tech/Sci/R&D Officer	2021-07-31
Portland Holdings, Inc. Portland Holdings, Inc. Financial ConglomeratesFinance Operates as an investment company	Chief Tech/Sci/R&D Officer	2021-11-18

All active positions of Hubert Walinski

Former positions of Hubert Walinski

Companies	Position	End
AstraZeneca Canada, Inc. AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations	Chief Tech/Sci/R&D Officer	2021-06-30

See the detail of Hubert Walinski's experience

Education of Hubert Walinski

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hubert Walinski's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Cipher Pharmaceuticals, Inc. Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services	Health Technology
Portland Holdings, Inc. Portland Holdings, Inc. Financial ConglomeratesFinance Operates as an investment company	Finance
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AstraZeneca Canada, Inc. AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations	Health Technology
McMaster University McMaster University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aic Global Holdings, Inc. Aic Global Holdings, Inc. Aic Global Holdings, Inc. is a privately held investment company headquartered in Portland Holdings. Aic Global Holdings, Inc. owns a diverse portfolio of businesses in various sectors, including media, tourism, and financial services. The company's investment philosophy is focused on enabling Canadian technologies. The company has been involved in the construction of the world's first micro-modular reactor at the Canadian Nuclear Laboratories (CNL). Aic Global Holdings has also collaborated with MBM Holding on healthcare and clean energy sectors of national importance. The company has been appointed to the supervisory board of ITM Isotopen Technologien München AG, a pharmaceutical group of companies. The company is based in Burlington, Canada. The CEO of the company is Joseph Sferrazza.